Joe Nolan, Jaguar CEO (Jaguar)

Jaguar, Sean Nolan's lat­est biotech, rais­es $139M as they fol­low Taysha's foot­steps

Joe Nolan swears he isn’t try­ing to hur­tle Jaguar Gene Ther­a­py to­ward a 0-to-60 IPO, but it sure looks like it.

Less than two months af­ter launch­ing with Deer­field cash and ex-AveX­is lead­er­ship, Jaguar an­nounced Tues­day they raised a $139 mil­lion Se­ries B led by Eli Lil­ly and Deer­field. That rapid ac­cel­er­a­tion is rem­i­nis­cent of the last biotech launched by the old AveX­is team, when Sean Nolan and RA Ses­sions steered Taysha through back-to-back Se­ries A and B rounds be­fore land­ing a $157 mil­lion IPO last Sep­tem­ber, 5 months af­ter launch.

Endpoints News

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

Vice President

Alexandria Real Estate Equities

San Francisco, CA, USA